CRISPR Therapeutics AG (CRSP)
NASDAQ: CRSP · Real-Time Price · USD
40.72
+0.34 (0.83%)
At close: Dec 20, 2024, 4:00 PM
40.95
+0.23 (0.56%)
After-hours: Dec 20, 2024, 7:32 PM EST
CRISPR Therapeutics AG Analyst Ratings
Total Analysts
18
Consensus Rating
Buy
Price Target
$76.60
Upside
+88.11%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JMP Securities | JMP Securities | Buy Reiterates $86 | Buy | Reiterates | $86 | +111.20% | Dec 20, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $94 | Strong Buy | Maintains | $94 | +130.84% | Dec 10, 2024 |
| RBC Capital | RBC Capital | Hold Reiterates $53 | Hold | Reiterates | $53 | +30.16% | Nov 6, 2024 |
| Barclays | Barclays | Hold Maintains $59 → $55 | Hold | Maintains | $59 → $55 | +35.07% | Nov 6, 2024 |
| Needham | Needham | Strong Buy Reiterates $84 | Strong Buy | Reiterates | $84 | +106.29% | Nov 6, 2024 |
| RBC Capital | RBC Capital | Hold Maintains $60 → $53 | Hold | Maintains | $60 → $53 | +30.16% | Oct 4, 2024 |
| Truist Securities | Truist Securities | Strong Buy Maintains $120 → $100 | Strong Buy | Maintains | $120 → $100 | +145.58% | Aug 12, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Aug 8, 2024 |
| Stifel | Stifel | Hold Maintains $60 → $59 | Hold | Maintains | $60 → $59 | +44.89% | Aug 6, 2024 |
| Barclays | Barclays | Hold Maintains $67 → $59 | Hold | Maintains | $67 → $59 | +44.89% | Aug 6, 2024 |
| RBC Capital | RBC Capital | Hold Maintains $66 → $60 | Hold | Maintains | $66 → $60 | +47.35% | Aug 6, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $112 → $94 | Strong Buy | Maintains | $112 → $94 | +130.84% | Aug 6, 2024 |
| Needham | Needham | Strong Buy Maintains $88 → $84 | Strong Buy | Maintains | $88 → $84 | +106.29% | Aug 6, 2024 |
| Guggenheim | Guggenheim | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Jun 28, 2024 |
| Needham | Needham | Strong Buy Reiterates $88 | Strong Buy | Reiterates | $88 | +116.11% | Jun 27, 2024 |
| Piper Sandler | Piper Sandler | Buy Reiterates $105 | Buy | Reiterates | $105 | +157.86% | Jun 17, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.